LYOCELL
Lyotropic Therapeutics, Inc.
Mark For: LYOCELL® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 76373277 |
| Registration Number | 2824420 |
| Mark Literal Elements | LYOCELL |
| Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
| Mark Type | TRADEMARK |
| Standard Character Claim | No |
| Register | PRINCIPAL |
| Affidavit Text | SECT 15. SECT 8 (6-YR). |
| Current Location | TMEG LAW OFFICE 105 2010-03-31 |
| Basis | 1(a) |
| Class Status | SECTION 8 - CANCEL |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | Yes |
| Current Use | Yes |
| Intent To Use | No |
| Filed ITU | No |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Cancellation Code | 2 |
| Law Office Assigned | L50 |
| Employee Name | CASE, LEIGH CAROLINE |
Timeline
| 2000-04-30 | Date of First Use |
| 2000-04-30 | Date of Use In Commerce |
| 2002-02-22 | Application Filed |
| 2003-12-30 | Published |
| 2003-12-30 | Published for Opposition |
| 2004-03-23 | Trademark Registered |
| 2010-03-31 | Location: TMEG LAW OFFICE 105 |
| 2014-10-24 | Cancelled |
| 2014-10-24 | Status: Dead/Cancelled |
| 2014-10-24 | Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this |
| 2018-07-08 | Transaction Date |
Trademark Parties (Applicants & Owners)
| Party: |  Lyotropic Therapeutics, Inc. |
| Address | 10487 Lake Ridge Pkwy Suite 400 Ashland, VIRGINIA UNITED STATES 23005 |
| Legal Entity Type | Corporation |
| Legal Entity State | VIRGINIA |
Documents
 Application | IMAGE/TIFF | 2002-02-22 |
| Drawing | IMAGE/TIFF | 2002-02-22 |
 Duplicate Application | 2002-02-22 | |
| Duplicate Drawing | 2002-02-22 | |
| Specimen | IMAGE/TIFF | 2002-02-22 |
| Offc Action Outgoing | 2002-06-26 | |
| XSearch Search Summary | 2002-06-26 | |
| Paper Correspondence Incoming | IMAGE/TIFF | 2002-12-17 |
| Response to Office Action | 2002-12-17 | |
| Unclassified-Other | 2003-01-30 | |
| E-Mail Incoming | 2003-02-20 | |
| E-Mail Incoming | APPLICATION/XML | 2003-02-20 |
| E-Mail Outgoing | 2003-02-20 | |
| Offc Action Outgoing | 2003-02-20 | |
| Unclassified-Other | 2003-03-10 | |
| Fax Incoming | 2003-08-19 | |
| Fax Incoming | 2003-08-19 | |
| Paper Correspondence Incoming | 2003-08-20 | |
| Paper Correspondence Incoming | 2003-08-21 | |
| File Jacket | 2003-08-25 | |
| Specimen | 2003-08-25 | |
| Unclassified-Other | 2003-08-25 | |
| Notice of Publication | APPLICATION/XML | 2003-12-10 |
| Registration Certificate | 2004-03-23 | |
| Section 8 and 15 | 2010-03-19 | |
| Specimen | 2010-03-19 | |
| Notice of Acceptance Acknowledgement | 2010-03-31 | |
| Change of Address | APPLICATION/XML | 2013-05-14 |
Attorney of Record
Good, Services, and Codes
(CANCELLED)
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations consisting of nano and micro particles that contain bioactive agents and utilize lyotropic liquids and liquid crystals, and ingredients and components thereof for use in prevention and treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, circulatory system and blood, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central, peripheral, autonomous, sympathetic and parasympathetic nervous system, diseases or conditions of the muscle and motor system, diseases and conditions of the skeletal system and bone, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders, hormonal disorders, protein disorders, genetic disorders, immune system, and gynecological conditions. for use in the alleviation or prevention or suppression of pain and the administration of anesthesia, antipyretics, and anti-inflammatory agents, veterinary preparations consisting of nano and micro particles containing bioactive agents and utilize lyotropic liquids and liquid crystals, and ingredients and components thereof for use in prevention and treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, circulatory system and blood, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central, peripheral, autonomous, sympathetic and parasympathetic nervous system, diseases or conditions of the muscle and motor system, diseases and conditions of the skeletal system and bone, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders, hormonal disorders, protein disorders, genetic disorders, immune system, and gynecological conditions; for use in the alleviation or prevention or suppression of pain and the administration of anesthesia, antipyretics and anti-inflammatory agents. FIRST USE: 20000430. FIRST USE IN COMMERCE: 20000430
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations consisting of nano and micro particles that contain bioactive agents and utilize lyotropic liquids and liquid crystals, and ingredients and components thereof for use in prevention and treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, circulatory system and blood, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central, peripheral, autonomous, sympathetic and parasympathetic nervous system, diseases or conditions of the muscle and motor system, diseases and conditions of the skeletal system and bone, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders, hormonal disorders, protein disorders, genetic disorders, immune system, and gynecological conditions; for use in the alleviation or prevention or suppression of pain and the administration of anesthesia, antipyretics, and anti-inflammatory agents, veterinary preparations consisting of nano and micro particles containing bioactive agents and utilize lyotropic liquids and liquid crystals, and ingredients and components thereof for use in prevention and treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, circulatory system and blood, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central, peripheral, autonomous, sympathetic and parasympathetic nervous system, diseases or conditions of the muscle and motor system, diseases and conditions of the skeletal system and bone, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders, hormonal disorders, protein disorders, genetic disorders, immune system, and gynecological conditions; for use in the alleviation or prevention or suppression of pain and the administration of anesthesia, antipyretics and anti-inflammatory agents |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | 2014-10-24 | |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2013-05-14 | |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2010-03-31 | 59136 |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2010-03-31 | 59136 |
| TEAS SECTION 8 & 15 RECEIVED | 2010-03-19 | |
| REGISTERED-PRINCIPAL REGISTER | 2004-03-23 | |
| PUBLISHED FOR OPPOSITION | 2003-12-30 | |
| NOTICE OF PUBLICATION | 2003-12-10 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2003-09-15 | |
| CASE FILE IN TICRS | 2003-08-27 | |
| PAPER RECEIVED | 2003-08-21 | |
| PAPER RECEIVED | 2003-08-20 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2003-08-20 | |
| FAX RECEIVED | 2003-08-19 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2003-08-19 | |
| UNRESPONSIVE/DUPLICATE PAPER RECEIVED | 2003-02-20 | |
| NON-FINAL ACTION E-MAILED | 2003-02-20 | |
| PAPER RECEIVED | 2002-12-17 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2002-12-17 | |
| ASSIGNED TO EXAMINER | 2002-10-18 | 72146 |
| NON-FINAL ACTION MAILED | 2002-06-27 | |
| ASSIGNED TO EXAMINER | 2002-06-12 | 77782 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 